Markets

Zacks Investment Ideas feature highlights: Floor & Decor Holdings, Verona Pharma, Emerald Expositions Events, Carvana and Couldera

For Immediate Release

Chicago, IL - May 01, 2017 - Today, Zacks Investment Ideas feature highlights Features: Floor & Decor Holdings (NYSE: FND- Free Report ), Verona Pharma (NASDAQ: VRNA- Free Report ), Emerald Expositions Events (NYSE: EEX- Free Report ), Carvana (NYSE: CVNA- Free Report ) and Couldera (NYSE: CLDR- Free Report ).

IPOs Tell Us the Market Is Moving Higher

The IPO window is wide open, as a number of new stocks came to the market for the first time this week. Today we have a few new names so let's take a look at them which stocks are set to see new coverage next week.

8 IPO's

One of the more successful deals this week was Floor & Decor Holdings (NYSE: FND- Free Report ) which priced 8.82M shares at $21, well above the $16-$18 expected range. The stock opened at $30.25 and has traded as high as $32.45. The CEO appeared on new media and suggest a reason for the success for the company has been the money invested in stores. This has helped the company compete with Home Depot and Amazon.

Seeing far less action was Verona Pharma (NASDAQ: VRNA- Free Report ) which increased the offering size from 4.45M to 5.77M shares and priced them at $13.50, a penny above the expected range. Since the IPO yesterday, the stock has basically held serve right at $13.50. I see only about 20K shares traded today, so this stock will likely remain rather thin.

Two Weaker Deals

Emerald Expositions Events (NYSE: EEX- Free Report ) saw the expected range of 18-20 turn out to be a bit too much and they priced 15.5M shares at $17. The stock opened at $18.73 and at the time of writing this it was trading at $19.29, up 2.29 for a 13% gain. Despite the weak pricing, investors have decided to give this trade show company a chance.

Carvana (NYSE: CVNA- Free Report ) is a platform for buying used cars, and they priced shares at the middle of the expected range of $14-$16. While the 15M shares were sold at $15, they opened much softer at $13.71. The stock continued to slide at I see it hitting a low of $12.50 on stiff volume of 7.5M shares.

Head In The Clouds

It seems that cloud stocks just keep coming and today we have another one with an interesting valuation story. Couldera (NYSE: CLDR- Free Report ) priced 15M shares at $15, one dollar over the top of the expected range. The stock opened at $17.86 and ran up to $19 and could be destined for a higher price or maybe even a deal down the road.

I make that speculation because the company saw a $766.5M investment from Intel back in 2014 at a valuation of just under $31 per share. That means the $15 IPO price is a brutal beat down of more than 50% for the chip maker. That said, could they be looking to buy the other 78% of the company they don't already own? At this price, it wouldn't be surprising to see the company add to their position.

Shares of CLDR topped out around $19.33 today, but over the longer term this stock could one to watch.

Why This Is All Good In The 'Hood

The stock market was stronger this week due to the French elections and the anticipation of Trump Tax reform. Lost in those bigger stories was the strong IPO market which means that the economy in general is likely to remain strong.

Venture capital companies are seeing more exits and then putting more cash to work in new company's. This is a big part of the economic lifecycle, so seeing several strong IPOs this week is a good thing.

Four deals are slated to price next week, so the hits look to keep coming and that tells me the market is probably going to continue moving higher.

Brian Bolan is the Aggressive Growth Stock Strategist at Zacks Investment Research. You can follow his article by clicking the follow the author button above or find him on Twitter: BBolan1

Want more articles from this author? Go to Zacks.com on this article and click the FOLLOW AUTHOR button to get an email each time a new article is published.

Brian Bolan is a Stock Strategist for Zacks.com.

He runs Stocks Under $10 Investor service where he looks for low priced stocks that are seeing positive earnings estimate revisions. This popular service has seen some strong early returns and offers a free trial via the Zacks Ultimate service.

Brian also runs the brand new Zacks Game Changers where he looks for stocks that are disrupting their industries and reaping big gains.

Looking for Ideas with Even Greater Upside?

Today's investment ideas are short-term, directly based on our proven 1 to 3 month indicator. In addition, I invite you to consider our long-term opportunities. These rare trades look to start fast with strong Zacks Ranks, but carry through with double and triple-digit profit potential. Starting now, you can look inside our home run, value, and stocks under $10 portfolios, plus more. Click here for a peek at this private information>>

Get the full Report on FND - FREE

Get the full Report on VRNA - FREE

Get the full Report on EEX - FREE

Get the full Report on CVNA - FREE

Get the full Report on CLDR - FREE

Follow us on Twitter: https://twitter.com/ZacksResearch

Join us on Facebook: https://www.facebook.com/ZacksInvestmentResearch

Zacks Investment Research is under common control with affiliated entities (including a broker-dealer and an investment adviser), which may engage in transactions involving the foregoing securities for the clients of such affiliates.

Media Contact

Zacks Investment Research

800-767-3771 ext. 9339

support@zacks.com

https://www.zacks.com/performance

Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performance for information about the performance numbers displayed in this press release.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

To read this article on Zacks.com click here.

Zacks Investment Research

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.


The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

In This Story

CLDR VRNA EEX FND CVNA

Other Topics

Stocks

Latest Markets Videos